These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11549586)
1. The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains. Schmidt ML; Schuck T; Sheridan S; Kung MP; Kung H; Zhuang ZP; Bergeron C; Lamarche JS; Skovronsky D; Giasson BI; Lee VM; Trojanowski JQ Am J Pathol; 2001 Sep; 159(3):937-43. PubMed ID: 11549586 [TBL] [Abstract][Full Text] [Related]
2. A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114. Crystal AS; Giasson BI; Crowe A; Kung MP; Zhuang ZP; Trojanowski JQ; Lee VM J Neurochem; 2003 Sep; 86(6):1359-68. PubMed ID: 12950445 [TBL] [Abstract][Full Text] [Related]
3. Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques. Sato K; Higuchi M; Iwata N; Saido TC; Sasamoto K Eur J Med Chem; 2004 Jul; 39(7):573-8. PubMed ID: 15236837 [TBL] [Abstract][Full Text] [Related]
4. Isomerization of (Z,Z) to (E,E)1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene in strong base: probes for amyloid plaques in the brain. Lee CW; Zhuang ZP; Kung MP; Plössl K; Skovronsky D; Gur T; Hou C; Trojanowski JQ; Lee VM; Kung HF J Med Chem; 2001 Jul; 44(14):2270-5. PubMed ID: 11428920 [TBL] [Abstract][Full Text] [Related]
5. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Skovronsky DM; Zhang B; Kung MP; Kung HF; Trojanowski JQ; Lee VM Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7609-14. PubMed ID: 10861023 [TBL] [Abstract][Full Text] [Related]
6. Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene]. Velasco A; Fraser G; Delobel P; Ghetti B; Lavenir I; Goedert M FEBS Lett; 2008 Mar; 582(6):901-6. PubMed ID: 18291106 [TBL] [Abstract][Full Text] [Related]
7. Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies. Ishikawa K; Doh-Ura K; Kudo Y; Nishida N; Murakami-Kubo I; Ando Y; Sawada T; Iwaki T J Gen Virol; 2004 Jun; 85(Pt 6):1785-1790. PubMed ID: 15166464 [TBL] [Abstract][Full Text] [Related]
8. [Novel tool for diagnosis of amyloidosis]. Obayashi K; Ando Y Rinsho Byori; 2008 Nov; 56(11):986-93. PubMed ID: 19086454 [TBL] [Abstract][Full Text] [Related]
9. Labeling of the scrapie-associated prion protein in vitro and in vivo. Hoefert VB; Aiken JM; McKenzie D; Johnson CJ Neurosci Lett; 2004 Nov; 371(2-3):176-80. PubMed ID: 15519752 [TBL] [Abstract][Full Text] [Related]
10. A novel tool for detecting amyloid deposits in systemic amyloidosis in vitro and in vivo. Ando Y; Haraoka K; Terazaki H; Tanoue Y; Ishikawa K; Katsuragi S; Nakamura M; Sun X; Nakagawa K; Sasamoto K; Takesako K; Ishizaki T; Sasaki Y; Doh-ura K Lab Invest; 2003 Dec; 83(12):1751-9. PubMed ID: 14691293 [TBL] [Abstract][Full Text] [Related]
11. The Congo red derivative FSB binds to curli amyloid fibers and specifically stains curliated E. coli. Reichhardt C; Cegelski L PLoS One; 2018; 13(8):e0203226. PubMed ID: 30161215 [TBL] [Abstract][Full Text] [Related]
12. Multiple ligand interaction of alpha-synuclein produced various forms of protein aggregates in the presence of Abeta25-35, copper, and eosin. Kim YS; Lee D; Lee EK; Sung JY; Chung KC; Kim J; Paik SR Brain Res; 2001 Jul; 908(1):93-8. PubMed ID: 11457435 [TBL] [Abstract][Full Text] [Related]
13. Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease. Kung MP; Hou C; Zhuang ZP; Skovronsky DM; Zhang B; Gur TL; Trojanowski JQ; Lee VM; Kung HF J Mol Neurosci; 2002; 19(1-2):7-10. PubMed ID: 12212796 [TBL] [Abstract][Full Text] [Related]
14. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. Styren SD; Hamilton RL; Styren GC; Klunk WE J Histochem Cytochem; 2000 Sep; 48(9):1223-32. PubMed ID: 10950879 [TBL] [Abstract][Full Text] [Related]
15. Detection of aggregates and protein inclusions by staining of tissues. Galvin JE Methods Mol Biol; 2003; 232():149-64. PubMed ID: 12840547 [No Abstract] [Full Text] [Related]
16. Alpha-synuclein: its biological function and role in neurodegenerative diseases. Kaplan B; Ratner V; Haas E J Mol Neurosci; 2003 Apr; 20(2):83-92. PubMed ID: 12794302 [TBL] [Abstract][Full Text] [Related]
17. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases. Lee VM; Giasson BI; Trojanowski JQ Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877 [TBL] [Abstract][Full Text] [Related]
18. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Takeda A; Mallory M; Sundsmo M; Honer W; Hansen L; Masliah E Am J Pathol; 1998 Feb; 152(2):367-72. PubMed ID: 9466562 [TBL] [Abstract][Full Text] [Related]
19. Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology. Galvin JE; Giasson B; Hurtig HI; Lee VM; Trojanowski JQ Am J Pathol; 2000 Aug; 157(2):361-8. PubMed ID: 10934140 [TBL] [Abstract][Full Text] [Related]
20. X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease. Ikonomovic MD; Abrahamson EE; Isanski BA; Debnath ML; Mathis CA; Dekosky ST; Klunk WE Methods Enzymol; 2006; 412():123-44. PubMed ID: 17046656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]